Viking Global Investors is a global investment firm managing more than twenty billion in capital across long-short equity and long-only strategies. The firm was established in 1999 and has offices in Greenwich, New York City, Hong Kong, and London.
Phone: 212-672-7000
280 Park Ave
# 33W1
New York, 10017
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-01 | Birchbox | Acq - Fin | $15M | |
| 2018-04-05 | Eidos Therapeutics | Series B | $64M | Aisling Capital, Amzak Capital Management, BridgeBio Pharma, Cormorant Asset Management, Janus Henderson Global Investors, Perceptive Advisors, and RA Capital Management |
| 2018-02-27 | Boost Biomes | Seed VC | $2.05M | Nimble Ventures, and Tencent Holdings |
| 2018-02-21 | PROCEPT BioRobotics | Series E | $118M | CPMG, Perceptive Advisors, and Undisclosed Investors |
| 2018-02-01 | Moderna Therapeutics | Series G | $500M | Abu Dhabi Investment Authority, Alexandria Venture Investments, ArrowMark Partners, BB Biotech Ventures, EDBI, Fidelity Investments, Julius Baer, Pictet Group, and Sequoia Capital China |
